Tandem Diabetes Care reported $-15338000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2912M 376M
Abiomed ABMD:US $ 65M 59K
Accuray ARAY:US $ -292000 4.27M
Align Technology ALGN:US $ 198.08M 22.81M
Atricure ATRC:US $ -14150000 1.65M
Baxter International BAX:US $ 531M 108M
Becton, Dickinson and BDX:US $ 805M 105M
Boston Scientific BSX:US $ 781M 237M
Cardiovascular Systems CSII:US $ -9647000 1.09M
Cooper Companies COO:US $ 136.8M 8.3M
Dexcom DXCM:US $ 41.3M 12.6M
Edwards Lifesciences EW:US $ 445.9M 64.4M
Globus Medical GMED:US $ 48.71M 22.62M
Inogen INGN:US $ -14216000 9.27M
Insulet PODD:US $ 37.9M 11.8M
Integra Lifesciences IART:US $ 63.86M 10.85M
Masimo MASI:US $ 59.74M 17.67M
Natus Medical BABY:US $ 6.23M 7.5M
Orthofix International OFIX:US $ -3078000 5.48M
Stryker SYK:US $ 770M 437M
Tandem Diabetes Care TNDM:US $ -15338000 28.08M